Nasal mucosa-derived extracellular vesicles

1 paper5 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Animals1

Outcomes

Osteogenic capacity

upin human cells1

1 study

Nasal mucosa-derived extracellular vesicles improve osteogenic capacity in human cells.
“restore proliferation and osteogenic capacity”
Cells
Nasal Mucosa-Derived Extracellular Vesicles as a Systemic Antiaging Intervention
Advanced science (Weinheim, Baden-Wurttemberg, Germany)21 Nov 2025

Senescence phenotypes

downin human cells1

1 study

Nasal mucosa-derived extracellular vesicles decrease senescence phenotypes in human cells.
“nmEVs alleviate senescence phenotypes in aged human bone marrow mesenchymal stem cells”
Cells
Nasal Mucosa-Derived Extracellular Vesicles as a Systemic Antiaging Intervention
Advanced science (Weinheim, Baden-Wurttemberg, Germany)21 Nov 2025

Circadian clock

upin mice1

1 study

Nasal mucosa-derived extracellular vesicles activate circadian clock in mice.
“restoring circadian rhythmicity”
Animals
Nasal Mucosa-Derived Extracellular Vesicles as a Systemic Antiaging Intervention
Advanced science (Weinheim, Baden-Wurttemberg, Germany)21 Nov 2025

Latest

1 in 12 months

Advanced Science22 Nov